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Abstract
Background: Complement C1q tumor necrosis factor related proteins (CTRPs) have been proved to have diverse
biological influences on cardiovascular system. CTRP 1 is a member of the CTRP superfamily, however, the
relevance with coronary artery disease (CAD) are seldom explored. This study was designed to investigate the
correlation between serum levels of CTRP 1 and CAD.
Methods: CTRP 1 levels of 150 CAD patients and 50 non-CAD subjects were determined by enzymelinked
immunosorbent assay. Further analysis of CTRP 1 levels in different stages and lesion vessels of CAD were
conducted.
Results: Serum levels of CTRP 1 in CAD patients were significantly elevated, and it was increased with the severity
of CAD. CTRP 1 level in acute myocardial infarction group was much higher than that in stable/unstable angina and
non-CAD groups. And significant differences of CTRP 1 were also found between single-vessel disease and triple-vessel
disease. Multiple logistic regression analysis showed that CTRP 1 was an independent risk factor of the occurrence of
myocardial infarction.
Conclusions: Increased serum CTRP 1 levels were closely associated with the prevalence and severity of CAD, it might
be regarded as a marker for myocardial infarction.
Keywords: Complement C1q tumor necrosis factor related protein 1, Coronary artery disease, Acute myocardial
infarction
Background
Complement C1q tumor necrosis factor related proteins
(CTRPs) superfamily is a cluster of adipokines, currently,
15 members are identified [1]. The highly conserved
family of proteins share a similar modular organization
to adiponectin and contain four distinct domains [2].
The members of CTRPs participate in the regulation of
physiological and pathological processes, such as glucose
and lipid metabolism, inflammation, myocardial protec-
tion, vasodilatation. CTRP 1 is identified as an adipokine,
its expression is greatly increased in adipose tissue of db/
db mice and Zucker diabetic fatty (fa/fa) rats [3]. It has
been reported that the levels of CTRP 1 were significantly
up-regulated in hypertensive patients’ serum [4]. Further-
more, CTRP 1 prevents collagen-induced platelet aggrega-
tion by specific blockade of von Willebrand’s factor
binding to collagen, which suggests that CTRP 1 could be
acted as a potent antithrombotic factor [5]. A recent study
revealed that serum CTRP 1 levels were significantly in-
creased in patients with type 2 diabetes mellitus, CTRP 1
was a novel adipokine associated with type 2 diabetes mel-
litus in humans [6]. The study by Shen and her colleagues
[7] demonstrated that CTRP 1 could inhibit in vitro
angiogenesis of endothelial progenitor cells from patients
with severe coronary artery disease.
Coronary artery disease (CAD) is one of the most
prevalent cardiovascular diseases, it is a group of dis-
eases that included: stable angina, unstable angina, myo-
cardial infarction, and sudden coronary death [8]. In
2013, CAD was the most common cause of death
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globally [9]. Multiple risk factors for CAD have been
identified, including smoking, family history, hypertension,
obesity, diabetes, lack of exercise, stress, and high blood
lipids [10]. CTRP has also been shown to have diverse bio-
logical influences on cardiovascular system [7]. Pervious
observations showed that CTRP 1 is associated with meta-
bolic and vascular disorders, and those disorders are con-
tributed to the pathogenesis of angiocardiopathy.
Among the extensive researches on the pathogenesis
of cardiovascular disease, the role of adipokines has been
gradually drawn more and more researchers’ attention
[11]. Adipose tissue is not only considered as energy tis-
sue, but also as an important endocrine organ that de-
rives a number of biologically active adipokines. These
adipokines exert the extraordinary biological functions.
CTRP 1 is a member of the CTRP superfamily and
express at high levels in adipose tissues. But there were
little research explored the relevance of CTRP 1 with
CAD. Hence, we developed a study regarding CTRP 1
and its relation with the prevalence or severity of CAD.
Methods
Subjects
A total of 200 participants who have underwent coronary
angiography successfully at the Department of Cardiology,
The 305 Hospital of the People’s Liberation Army were
enrolled in the study between January 2010 and January
2012. The subjects included 133 males and 67 females,
the average age was 61.11 ± 11.83 years. Stable and
unstable angina pectoris were determined by American
College of Cardiology (ACC)/American Heart Association
(AHA) 2007 guidelines [12], the diagnosis of acute myo-
cardial infarction was performed according to the clinical
history, electrocardiogram and serum myocardial enzymo-
gram. With the reference of their clinical diagnosis and
coronary angiography results, they were divided into CAD
group (n = 150) and non-CAD group (n = 50, with normal
coronary artery angiogram). And CAD group further
grouped into 3 subgroups by their clinical course: stable
angina (SA) group (n = 48), unstable angina (UA) group
(n = 43) and acute myocardial infarction (AMI) group
(n = 59). The participants with cerebral infarction,
thrombotic diseases, valvular heart disease, severe hepatic
and renal dysfunction, tumors, infections and hematologic
disorders were excluded. All of them were given written
informed consent. This study was approved by the ethics
committee of The 305 Hospital of the People’s Liberation
Army.
Methods
Blood samples were obtained within 24 h of admission
from all the participants. Peripheral venous blood cells
were isolated by density gradient centrifugation and the
serum was stored at −70 °C. CTRP 1 levels were
determined quantitatively with enzyme-linked immuno-
sorbent assay using the commercially available ELISA kit
(Cloud-Clone Corp) and followed the manufacturer’s
recommendations. Other serum indexes were measured
by routine methods using a fully automatic biochemical
analyzer (UniCel DxC 800 Synchron, Beckman Coulter,
Inc., USA).
The Seldinger technique was used in the coronary
angiography. A GE300 cardiovascular angiographic sys-
tem was used to show lesion location. According to dif-
ferent parts involved, the lesion can be classified into left
main, anterior descending, circumflex and right coronary
artery lesion. A stenosis ≥ 50 % was considered as CAD,
and left main stenosis ≥ 50 % was considered as double-
vessel disease.
Statistical analysis
Statistical analyses were performed using SPSS 17.0 soft-
ware. The measurement data were conducted by normal-
ity test. Continuous variables were presented as mean ±
standard deviation (SD). The difference of measurement
data was compared with t test between groups. Tukey’s
test was used for pairwise comparison between groups.
Count data were assessed using chi-square test. Logistic
regression analysis was used to identify the associ-
ation between CAD and other variables. All statistical




Clinical characteristics of CAD patients and non-CAD
subjects are listed in Table 1. The proportion of male,
smoking and diabetes were observed more frequently in
CAD group. CAD patients had significantly higher levels
of glucose, creatinine (CRE) and CTRP 1 than non-CAD
group. High density lipoprotein-cholesterol (HDL-c)
level was lower in CAD group than that in non-CAD
group. There were no statistical differences in triglycer-
ide (TG), total cholesterol (TC), low density lipoprotein-
cholesterol (LDL-c), urea nitrogen and uric acid between
the two groups.
Relationship between CTRP 1 and different stages of CAD
To further clarify the correlation between the increased
levels of CTPR 1 and the severity of CAD, we compared
CTRP 1 level of different subgroups. CAD patients were
grouped by the development of the disease, the CTRP 1
level (Fig. 1) in SA, UA and AMI group was 7.33 ± 6.46,
9.30 ± 4.94 and 12.52 ± 10.60 ng/mL, respectively. CTRP
1 levels in AMI group was significantly higher than that
in SA, UA and non-CAD groups (P < 0.01). But the dif-
ferences were not significant between SA, UA and non-
CAD groups. When grouped according to different
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coronary lesion vessels, the CTRP 1 level (Fig. 2) in
single-vessel, double-vessel and triple-vessel disease
group was 7.82 ± 5.14, 10.40 ± 8.66 and 13.42 ± 10.11 ng/
mL, respectively. CTRP 1 levels increased with the cor-
onary lesion vessels, it was markedly different between
single-vessel and triple-vessel disease group (P < 0.01).
There had no difference in single-vessel and double-
vessel disease group, double-vessel and triple-vessel dis-
ease group.
Association of CTRP 1 levels with myocardial infarction
To confirm the association between CTRP 1 and myo-
cardial infarction, multiple logistic regression analysis
was performed between AMI and non-CAD groups
(Table 2). Gender, age, systolic/diastolic blood pressure,
glucose, TG, TC, HDL-c, LDL-c and CTRP 1 were
regarded as independent variables. The result demon-
strated that gender, glucose and CTRP 1 were independ-
ent risk factors associated with myocardial infarction.
Discussion
Our study demonstrated that the CTRP 1 levels were in-
creased in patients with CAD compared to non-CAD
subjects, and the CTRP 1 levels were on an upward
trend with the progress of disease. Multiple logistic
regression analysis showed that increased CTRP 1 level
was independent risk factor of myocardial infarction.
Some studies have indicated that CTRP family mem-
bers, including adiponectin, CTRP 3 and CTRP 9, were
involved in the regulation of cardiovascular disease in
mice and human. For example, CTRP 3 has been found
Table 1 Clinical characteristics of participants in CAD and
non-CAD groups
Non-CAD (n = 50) CAD (n = 150) P
Male (%) 24 (48) 109 (72.7) 0.001**
Age (years) 59.88 ± 9.31 61.57 ± 11.77 0.881
Smoking (%) 8 (16) 56 (37.3) 0.005**
Alcohol (%) 8 (16) 26 (17.3) 0.967
Hypertension (%) 18 (36) 77 (51.3) 0.06
Diabetes (%) 8 (16) 48 (32) 0.029*
Hyperlipidaemia (%) 16 (32) 60 (40) 0.313
TG (mmol/L) 1.60 ± 1.80 1.70 ± 1.41 0.732
TC (mmol/L) 4.13 ± 0.85 4.02 ± 1.17 0.506
HDL-C (mmol/L) 1.11 ± 0.20 0.90 ± 0.25 0.02*
LDL-C (mmol/L) 2.40 ± 0.85 2.37 ± 1.02 0.857
Glucose (mmol/L) 5.59 ± 1.06 6.53 ± 2.46 0.003**
Urea nitrogen (mmol/L) 4.94 ± 1.29 5.46 ± 1.59 0.102
CRE (μmol/L) 66.20 ± 14.92 75.48 ± 19.07 0.02*
Uric acid (μmol/L) 311.06 ± 77.45 338.86 ± 106.21 0.156
CTRP1 (ng/mL) 6.91 ± 2.80 10.20 ± 8.89 0.031*
Compared with non-CAD group, *P < 0.05, **P < 0.01
Fig. 1 CTRP 1 levels in patients with SA, UA, AMI and non-CAD subjects
Fig. 2 CTRP 1 levels in patients with single-vessel, double-vessel and
triple-vessel disease
Table 2 Logistic regression analysis of related risk factors for
CAD
OR 95 % CI P
Male 0.220 0.052–0.920 0.018
Systolic pressure 1.017 0.954–1.084 0.614
Diastolic pressure 0.957 0.864–1.061 0.406
Glucose (mmol/L) 1.714 1.022–2.875 0.041
TG (mmol/L) 0.787 0.321–1.925 0.599
TC (mmol/L) 0.502 0.018–13.993 0.685
HDL-c (mmol/L) 0.562 0.010–30.630 0.777
LDL-c (mmol/L) 1.734 0.072–41.723 0.735
CTRP1 (ng/mL) 1.319 1.053–1.652 0.016
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to be associated with cardiac risk factors in human [13].
Yi [14] first demonstrated that the expression and pro-
duction of CTRP 3 were significantly reduced after
myocardial infarction, the administration of CTRP 3
could improve survival rate and restore cardiac func-
tion in mice with coronary artery occlusion. Animal
experiments showed that CTRP 9 administration to
mice significantly reduced infarct size and improved
cardiac function [15], and CTRP 9 protected against
acute cardiac injury following ischemia-reperfusion via
an AMPK-dependent mechanism [16]. Furthermore,
CTRP 9 was also a vasorelaxative adipocytokine that
exerted vasculoprotective effects [17].
In recent study, increased serum CTRP 1 level in
SA patients were observed [7]. Consistent with these
findings, our data in this study indicated that CTRP 1
levels in CAD group were significantly higher than
non-CAD group. It has also been reported that CTRP
1 levels were elevated with the disease progresses and
coronary lesion vessels. All these observations proved
that CTRP 1 level were closely related to the patho-
genesis and severity of CAD. Previous studies have
reported that CTPR 1 were significantly increased in
subjects with hypertension [4], diabetes [6], as well as
metabolic syndrome [18]. Because these diseases were
the recognized risk factors for atherosclerosis, in
order to test whether our findings were influenced by
those factors, multivariate stepwise regression analysis
was performed to evaluate the independent factors of
myocardial infarction with the above factors. Gender,
glucose and CTRP 1 were the independent risk fac-
tors. It was obvious that metabolic abnormalities in-
duced by CAD affected CTRP 1 levels more or less,
but the increased CTRP 1 levels probably not related
to them completely. The body’s inflammatory states
and mutual adjustment between other members in
CTRP superfamily might also contribute the enhance-
ment of CTRP 1.
Conclusion
The actual role of CTRP 1 in the cardiovascular system
is completely unknown [19]. However, the increased
CTRP 1 were closed related with CAD, suggesting
CTRP1 levels might serve as a predictor of CAD. There-
fore, CTRP 1 levels in CAD patients should be paid
highly attentions. There were important potential for
CTRP 1 to be used as a novel biomarker to evaluate car-
diovascular risk, but the assumption needed future clarifi-
cation after acquiring the exact mechanism. The future
study should conduct on a larger population, and potential
confounding factors such as obesity should be excluded.
Meanwhile, as a member of complex CTRP family, the
interrelationship of other members with different bio-
logical function should be considered.
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